Characteristic | Patients (n = 27) | (%) |
---|---|---|
Male | 23 | 85.2 |
Female | 4 | 14.8 |
Age (y) | ||
 Range | 50-90 |  |
 Median | 70 |  |
T stage | ||
 T3 | 25 | 92.6 |
 T4 | 2 | 7.4 |
N stage | ||
 N0 | 0 | 0 |
 N1 | 16 | 59.3 |
 N2 | 10 | 37.0 |
 N3 | 1 | 3.7 |
Stage | ||
 IIIA | 15 | 55.6 |
 IIIB | 9 | 33.3 |
 IIIC | 3 | 11.1 |
Location of the lesion | ||
 Ut | 5 | 18.5 |
 Mt | 9 | 33.3 |
 Mt./Lt | 6 | 22.2 |
 Lt | 5 | 18.5 |
 Lt/Ae | 2 | 7.4 |
Chemotherapy | ||
 5-Fu + CDDP | 16 | 59.3 |
 5-Fu + nedaplatin | 7 | 25.9 |
 5-Fu | 1 | 3.7 |
 Radiotherapy alone | 3 | 11.1 |